PMID: 8962137Dec 10, 1996Paper

Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity

Proceedings of the National Academy of Sciences of the United States of America
C NaftzgerA N Houghton

Abstract

Recognition of self is emerging as a theme for the immune recognition of human cancer. One question is whether the immune system can actively respond to normal tissue autoantigens expressed by cancer cells. A second but related question is whether immune recognition of tissue autoantigens can actually induce tumor rejection. To address these issues, a mouse model was developed to investigate immune responses to a melanocyte differentiation antigen, tyrosinase-related protein 1 (or gp75), which is the product of the brown locus. In mice, immunization with purified syngeneic gp75 or syngeneic cells expressing gp75 failed to elicit antibody or cytotoxic T-cell responses to gp75, even when different immune adjuvants and cytokines were included. However, immunization with altered sources of gp75 antigen, in the form of either syngeneic gp75 expressed in insect cells or human gp75, elicited autoantibodies to gp75. Immunized mice rejected metastatic melanomas and developed patchy depigmentation in their coats. These studies support a model of tolerance maintained to a melanocyte differentiation antigen where tolerance can be broken by presenting sources of altered antigen (e.g., homologous xenogeneic protein or protein expressed in in...Continue Reading

References

Jan 21, 1991·International Journal of Cancer. Journal International Du Cancer·S Vijayasaradhi, A N Houghton
Jul 1, 1991·Clinical and Experimental Dermatology·P Duhra, A Ilchyshyn
Apr 1, 1990·The Journal of Experimental Medicine·S VijayasaradhiA N Houghton
Mar 25, 1986·Nucleic Acids Research·S ShibaharaR Müller
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R J CoteL J Old
Nov 1, 1986·The Journal of Experimental Medicine·J Miller, R N Germain
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P O LivingstonL J Old
Apr 4, 1973·Nature: New Biology·I J Fidler
Dec 15, 1967·Science·B Mintz, W K Silvers
Nov 1, 1983·Journal of the American Academy of Dermatology·J J NordlundA B Lerner
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·A N HoughtonL J Old
May 5, 1982·Journal of Molecular Biology·J Kyte, R F Doolittle
Dec 1, 1982·The Journal of Experimental Medicine·A N HoughtonL J Old
Jun 1, 1995·Immunological Reviews·A Van PelT Boon
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·P G CoulieT Boon
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·S L TopalianS A Rosenberg
Jul 1, 1994·The Journal of Experimental Medicine·A N Houghton
Jun 2, 1994·Nature·D M Pardoll
May 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P O LivingstonG Ritter
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·T J Tsomides, H N Eisen
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y KawakamiS A Rosenberg
Aug 12, 1993·Annals of the New York Academy of Sciences·P O Livingston
Mar 1, 1996·The Journal of Experimental Medicine·P F RobbinsS A Rosenberg
Mar 1, 1996·The Journal of Experimental Medicine·T Boon, P van der Bruggen
Apr 1, 1996·The Journal of Experimental Medicine·N ZamzamiG Kroemer

❮ Previous
Next ❯

Citations

Oct 20, 2005·Cancer Immunology, Immunotherapy : CII·Bing HuXiao-wei Zhang
Oct 13, 2006·Cancer Immunology, Immunotherapy : CII·Andrea MarrariLicia Rivoltini
Jan 24, 2007·Cancer Immunology, Immunotherapy : CII·Mark A SuckowMartin Tenniswood
Feb 13, 2001·Vaccine·P Moingeon
Sep 28, 2000·Current Opinion in Immunology·R OffringaC J Melief
Mar 3, 2001·Current Opinion in Immunology·A N HoughtonN E Blachere
Jul 16, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Byram W BridleYonghong Wan
Apr 12, 2012·Nature Biotechnology·Francesca Avogadri, Jedd D Wolchok
Aug 30, 2001·Nature Immunology·E Gilboa
Nov 6, 1998·The Journal of Experimental Medicine·R DyallJ Nikolić-Zugić
Dec 10, 1999·The Journal of Experimental Medicine·W B BowneA N Houghton
Mar 17, 2004·The Journal of Experimental Medicine·Annika VogtErvin H Epstein
Apr 1, 2009·The Journal of Experimental Medicine·Gabrielle A RizzutoAlan N Houghton
May 23, 1998·Annual Review of Immunology·J V Ravetch, R A Clynes
Apr 15, 2006·The Journal of Clinical Investigation·José A Guevara-PatiñoAlan N Houghton
Sep 17, 1998·The Journal of Clinical Investigation·L W WeberA N Houghton
Apr 20, 2004·Journal of Translational Medicine·Roopa Srinivasan, Jedd D Wolchok
Jun 9, 2001·Critical Reviews in Immunology·W W Overwijk, N P Restifo
Jan 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·R ClynesJ V Ravetch
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·W W OverwijkN P Restifo
May 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·F Stephen HodiGlenn Dranoff
Nov 26, 2002·Immunological Reviews·Mary Jo TurkAlan N Houghton
Nov 4, 2000·Expert Opinion on Investigational Drugs·T H Scott-Taylor, A G Dalgleish
Jul 16, 2014·Expert Opinion on Biological Therapy·Federica CavalloGennaro Ciliberto
Jan 5, 2001·Expert Opinion on Investigational Drugs·H M HortonJ A Norman
Oct 9, 1998·The Journal of Investigative Dermatology·S K HuangD S Hoon
May 8, 2007·Experimental Parasitology·Natalia ReszkaKrystyna Bieńkowska-Szewczyk
Jan 30, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Victor I SeledtsovDmitriy V Seledtsov
Jun 10, 2006·Hematology/oncology Clinics of North America·Rodica StanAdam D Cohen
Nov 15, 2006·Immunological Reviews·Nevila Hyka-Nouspikel, Joseph H Phillips
Apr 3, 2002·Seminars in Cancer Biology·Miguel-Angel PeralesAlan N Houghton
May 17, 2005·Autoimmunity Reviews·Félix Fernández MadridJohn E Tomkiel
Oct 26, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Shigeo TamakiGotaro Toda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.